2
PROTECTING YOUR IP BIOTECHNOLOGY SECTOR BIOTECHNOLOGY SECTOR IN THE “The global biotechnology market is expected to reach EUR 650,000 million by 2025” An initiative of the Source: KPMC Competitive Alternatives 2014 Source: Grand View Research DID YOU KNOW? An adequate IPR strategy brings you the key to maximize your investment … that IPR protection and management is essential for biotech companies? …that within the Latin American agriculture sector there is a predominance of patents related to genetically modi ed organisms? Moreover, the majority of the R&D investment comes from outside Latin America biotechnology patents granted in Latin America in 2017 648 growth in biotech patents granted in Latin America (2016-2017) 6,6% of the worldwide biotechnology patents are granted in Latin America 2,7% “Latin America is forecasted to show moderate market growth, due to development in healthcare infrastructure, an increasing population that leads to increased food demand, growing government investments in R&D activities and the introduction of advanced technologies by leading companies” Source: Zion Market Research Source: WIPO Biotechnology patents in Latin America

BIOTECHNOLOGY SECTORBIOTECHNOLOGY SECTOR · 2019. 10. 16. · biotechnology sector Brazil could be the “next big thing” in biotechnology in the years up to 2020 Argentinian biotech

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: BIOTECHNOLOGY SECTORBIOTECHNOLOGY SECTOR · 2019. 10. 16. · biotechnology sector Brazil could be the “next big thing” in biotechnology in the years up to 2020 Argentinian biotech

PROTECTING YOUR IP

BIOTECHNOLOGY SECTORBIOTECHNOLOGY SECTORIN THE

“The global biotechnology market is expected to reach EUR 650,000 million by 2025”

An initiativeof the

Source: KPMC Competitive Alternatives 2014

Source: Grand View Research

DID YOU KNOW?

An adequate IPR strategy brings you the key to maximize your investment

… that IPR protection and management is essential for biotech companies?

…that within the Latin American agriculture sector there is a predominance of patents related to genetically modified organisms?Moreover, the majority of the R&D investment comes from outside Latin America

biotechnology patents granted in Latin America

in 2017

648 growth in biotech patents granted in

Latin America (2016-2017)

6,6%of the worldwide

biotechnology patents are

granted in Latin America

2,7%

“Latin America is forecasted to show moderate market growth, due to development in healthcare infrastructure, an increasing

population that leads to increased food demand, growing government investments in R&D activities and the introduction

of advanced technologies by leading companies”Source: Zion Market Research

Source: WIPO

Biotechnology patents in Latin America

Page 2: BIOTECHNOLOGY SECTORBIOTECHNOLOGY SECTOR · 2019. 10. 16. · biotechnology sector Brazil could be the “next big thing” in biotechnology in the years up to 2020 Argentinian biotech

www.latinamerica-ipr-helpdesk.eu@latinamericaipr

©European Union, 2019Reuse is authorised provided the source is acknowledged. The reuse policy of European Commission documents is regulated by Decision 2011/833/EU (OJ L 330, 14.12.2011, p.39).The Latin America IPR SME Helpdesk is a free service for SMEs which provides practical, objective and factual information about Intellectual Property Rights in Latin America. The services are not of a legal or advisory nature and no responsibility is accepted for the results of any actions made on the basis of its services. The content and opinions expressed are those of the authors and do not necessarily represent the views of the European Commission and/or the Executive Agency for Small and Medium-sized Enterprises or any other body of the European Union.Before taking specific actions in relation to IPR protection or enforcement all customers are advised to seek independent advice. Neither the European Commission nor the Agency may be held responsible for the use which may be made of the information contained herein.EA-03-19-504-EN-C — ISBN 978-92-9202-557-1 — doi:10.2826/21713EA-03-19-504-EN-N — ISBN 978-92-9202-556-4 — doi:10.2826/182004

fir

st li

ne assistance

for EU SMEs on IP in La

tin A

mer

ica

free service

[email protected]

Check out for more detailed information

An initiative of the

PROTECTING YOUR IP

BIOTECHNOLOGY SECTORBIOTECHNOLOGY SECTORIN THE

Biotechnology companies & research centres in Chile have significantly grown and are expected to achieve a 30% annual growth in the future

Patent grants in Mexico (2017): 5,7% from the biotechnology sector

Brazil could be the “next big thing” in biotechnology in the years up to 2020

Argentinian biotech businesses invoice over EUR 900 million annually, exporting a quarter of what is produced

Patent applications in Chile (2018):15.4% from the Biotechnology sector

Patent grants in Brazil (2017):3% from the biotechnology sector

Argentina’s greatest strengths: Seed production, micropropagation and livestock genetics, medicines and inoculants

• Patents are key IPRs in biotech

• Do not forget to verify national exclusions from patentability such as living matter, plants and animals or new use of patents

• Biotech patent applications may require additional filing requirements when the invention involves microorganisms or is based on genetic resources and traditional knowledge

Trademarks protect signs which identify your products and services in the market:

• Register them before introducing your invention onto the market

• Registration prevents competitors from taking advantage of the reputation of your Brand

Trade secrets could be used to protect: processes, laboratory notebooks, clinical trial data, clients’ lists, databases

To enjoy longer protection: implement confidentiality policies and measures e.g. Non-Disclosure Agreements

Source: INAPI

Source: WIPO Source: Science for Brazil

Source: WIPO

Source: WIPO

CHILE MEXICO BRAZIL ARGENTINA

TIPS AND WATCH-OUTSPATENTS TRADEMARKS TRADE SECRETS

C

to IPR protection or enforcement all customers are advised to seek independent n nor the Agency may be held responsible for the use which may be made of the

202-557-1 — doi:10.2826/21713202-556-4 — doi:10.2826/182004